The effects of intravenous sedative agents combined therapy for pediatrics
Not Applicable
Recruiting
- Conditions
- Diseases of the blood and blood -forming organs and certain disorders involving the immune mechanism
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 120
Inclusion Criteria
Pediatric patients who are scheduled to do bone marrow aspiration and biopsy in outpatient clinic.
Exclusion Criteria
less than 10 kilogram or over 40 kilogram in body weight
the pediatrics who have upper respiratory infection or fever.
the pediatrics who take the anticonvulsant or have neurologic abnormalities
the pediatrics who have prior sensitization or allergic to propofol, soy, egg products, or ketamine
the pediatrics who take the medicine related to current sedative agents
the pediatrics who already take the sedatives or analgesics
the refusal of participation in this study by parents
Study & Design
- Study Type
- Interventional Study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The frequency of adverse repiratory events during procedures
- Secondary Outcome Measures
Name Time Method the number of movement during procedure ;the duration from the end of procedure to emergence(awake);the adverse events by sedative agents